We investigated whether lipoamide and diacetyl-lipoamide are able to c
hange the substrate selection in post-ischaemic myocardium. This can b
e important, because shifting heart metabolism from fatty acid to carb
ohydrate oxidation can decrease ischaemic injury. Studying the metabol
ism of [1,2-C-13]diacetyl-lipoamide in situ in perfused rat heart by C
-13 n.m.r., we found intense C-13 labelling in glutamate and aspartate
, showing that acetyl groups from diacetyl-lipoamide are effectively t
ransferred to CoA and metabolized in heart tissue. From analysis of gl
utamate C-3 and C-4 isotopomers, we determined the [1,2-C-13]acetate/[
3-C-13]lactate utilization ratio in normoxic and postischaemic hearts,
where under our experimental conditions the acetate/lactate utilizati
on ratios were 1.2+/-0.2 and 2.4+/-0.3 in normoxic and post-ischaemic
hearts respectively. When 0.25 mM lipoamide was added to the perfusate
the acetate/lactate utilization ratio decreased to 1.4+/-0.1, which i
s almost equal to that found for normoxic hearts, showing that lipoami
de increased the lactate utilization. In accordance with these data, w
e found that lipoamide activated pyruvate dehydrogenase by 50% in post
ischaemic myocardium. Competition between [3-C-13]lactate and unlabell
ed octanoate was also studied in post-ischaemic hearts, and we found t
hat lipoamide increased lactate utilization by 100% and increased the
rate of the tricarboxylic acid cycle by 64%. Under the same experiment
al conditions, lipoamide significantly promoted the recovery of post-i
schaemic unpaced hearts, showing the positive effect of increased lact
ate oxidation in post-ischaemic myocardium.